Steven Cohen's position in Viridian Therapeutics is currently worth $5.28M. That's 0.01% of their equity portfolio (912th largest holding). The first Viridian Therapeutics trade was made in Q1 2021. Since then Steven Cohen bought shares seven more times and sold shares on ten occasions. The investor's estimated purchase price is $9.09M, resulting in a loss of 42%.